Skip to content
Clinical Trials – home

Specjalistyczne Gabinety Sp. z o.o.

Research site

Poland Pl. Lasoty 4, 30-539 Cracow, Poland

  • 4 trials recruiting
  • Migraine · Migraine with aura · Migraine without aura
  • Adults and children

About Specializations

Specjalistyczne Gabinety Sp. z o.o. in Cracow, Poland specialises in clinical trials of conditions such as Migraine, Migraine with aura, Migraine without aura, Cerebral palsy, and other specialisations. This site conducts important research.

Main research areas of the site

Neurology and Nervous System Diseases

At Specjalistyczne Gabinety Sp. z o.o. in Cracow, the clinical trial portfolio is strongly centered on migraine and other neurological disorders. Research here includes studies aimed at improving prevention and symptom control, especially for children, adolescents, and adults living with frequent headaches or related conditions.

  • Studies in chronic migraine, episodic migraine, and menstrual migraine
  • Trials evaluating new options for migraine prevention and long-term tolerability
  • Research focused on insomnia disorder and broader neurologic symptom management

This area reflects a clear effort to test new therapies that may help reduce headache burden and improve daily functioning for people affected by persistent nervous system conditions.

Movement Disorders and Spasticity

The site also supports research in musculoskeletal diseases and neurologic movement disorders, with studies addressing abnormal muscle tone, involuntary movements, and functional limitations after cerebral palsy, stroke, or traumatic brain injury.

  • Lower limb spasticity and upper limb spasticity in children and adults
  • Cervical dystonia and dyskinesia due to cerebral palsy
  • Trials designed to assess whether new treatments can improve movement control and daily comfort

These studies aim to improve treatment effectiveness for people with chronic motor symptoms, including patients seen through the Neurologia department.

Neuromuscular and Immune System Diseases

Clinical research at this site includes conditions where the nervous system and immune system overlap, such as generalized myasthenia gravis. The trials are focused on evaluating whether new treatment approaches can better control muscle weakness and support longer-term disease management.

  • Generalized myasthenia gravis studies
  • Evaluation of treatment safety, tolerability, and sustained benefit
  • Research into self-administration and patient-friendly treatment use

This work helps expand options for people with chronic immune-mediated neurologic disease, with an emphasis on practical treatment use in everyday care.

Oncology and Cardiovascular Diseases

The site contributes to research in neoplasms and cardiovascular diseases, including studies in prostate cancer, non-small cell lung cancer, and prevention of cancer-associated thrombosis. These trials are designed to improve treatment outcomes and reduce serious complications linked to cancer care.

  • Metastatic castration-sensitive prostate cancer
  • Early-stage non-small cell lung cancer
  • Cancer-associated thrombosis prevention during cancer treatment

This research broadens the site’s portfolio beyond neurology and reflects interest in testing therapies that may improve survival, safety, and quality of care for patients with complex oncology needs.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Pl. Lasoty 430-539 CracowPoland
Recruiting now
4 trials
Conditions studied
18

More sites in CracowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

21 clinical trials

Torticollis

Recruiting

Study on IPN10200 for Treating Cervical Dystonia in Adults

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum, Neurotoxin Serotype A/B
  • Sponsor:Ipsen Innovation

Migraine

Recruiting

Study on the Safety and Effectiveness of Atogepant for Preventing Chronic Migraine in Children Aged 12 to 17

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine+2

Recruiting

Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

Investigational
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Migraine+2

Recruiting

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Embolism

Not yet recruiting

A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:REGN7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Migraine

Not recruiting

Study of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum, Neurotoxin Serotype A/B
  • Sponsor:Ipsen Innovation

Migraine

Not recruiting

Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Muscle spasticity

Not recruiting

Study on the Safety and Effectiveness of IPN10200 for Treating Upper Limb Spasticity in Adults After Stroke or Brain Injury

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Ipsen Innovation

Myasthenia gravis

Not recruiting

Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zilucoplan
  • Sponsor:UCB Biopharma

Migraine

Not recruiting

Study on the Safety and Effectiveness of MEDI0618 for Reducing Migraine Days in Adults with Episodic Migraine

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:MEDI0618
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Parkinson's disease

Not recruiting

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Tavapadon
  • Sponsor:Cerevel Therapeutics LLC

Neuralgia

Not recruiting

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Merz Therapeutics GmbH
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.